AtriCure Inc (AtriCure) provides medical devices for the treatment of atrial fibrillation (Afib) and related conditions. The company's primary activities involve the development and distribution of medical devices used by electrophysiologists and cardiothoracic surgeons. AtriCure's major products include the Isolator Synergy ablation system, AtriClip left atrial appendage exclusion system, hybrid AF therapy, and cryoICE cryoSPHERE probe. These products are used in various surgical procedures, including open-heart and minimally invasive surgeries, to treat Afib and manage post-operative pain. The company markets and sells its products in markets outside the US through its European subsidiaries and independent distributors. It operates in the US, Germany, France, the UK, the Benelux region, Canada, and Australia, among other locations. AtriCure Inc is headquartered in Mason, Ohio, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AtriCure Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- AtriCure Inc Company Overview
- AtriCure Inc Company Snapshot
- AtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview
- AtriCure Inc - Pipeline Analysis Overview
- Business Description
- AtriCure Inc - Key Facts
- AtriCure Inc - Major Products and Services
- AtriCure Inc Pipeline Products by Development Stage
- AtriCure Inc Ongoing Clinical Trials by Trial Status
- AtriCure Inc Pipeline Products Overview
- AtriClip System - Stroke
- AtriClip System - Stroke Product Overview
- AtriClip System - Stroke Clinical Trial
- AtriCure Bipolar System
- AtriCure Bipolar System Product Overview
- AtriCure Bipolar System Clinical Trial
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST)
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) Product Overview
- CryoICE Ablation System - Atrial Fibrillation
- CryoICE Ablation System - Atrial Fibrillation Product Overview
- CryoICE Ablation System - Atrial Fibrillation Clinical Trial
- cryoSPHERE Cryoablation Probe - Sternotomy
- cryoSPHERE Cryoablation Probe - Sternotomy Product Overview
- Eclipse Surgical Left Atrial Appendage Closure Device
- Eclipse Surgical Left Atrial Appendage Closure Device Product Overview
- LARIAT Suture Delivery Device - Adjunctive Therapy
- LARIAT Suture Delivery Device - Adjunctive Therapy Product Overview
- Next Generation RF Generator
- Next Generation RF Generator Product Overview
- AtriCure Inc - Key Competitors
- AtriCure Inc - Key Employees
- AtriCure Inc - Key Employee Biographies
- AtriCure Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- AtriCure Inc, Recent Developments
- Jul 23, 2024: AtriCure Receives Regulatory Approval to Sell AtriClip Devices in China
- Feb 22, 2024: AtriCure Receives FDA 510(k) Clearance for EPi-Ease Epicardial Access Device (EAS)
- Nov 15, 2023: AtriCure Obtains Additional 510(K) Clearance For AtriClip LAA Exclusion System With Preloaded Gillinov-Cosgrove Pro-V Clip
- Nov 09, 2023: AtriCure Receives 510(K) Clearance For cryoICE cryoSPHERE+ Cryoablation Probe
- Nov 09, 2023: AtriCure Receives 510(K) Clearance For cryoICE cryoSPHERE MAX Cryoablation Probe
- Apr 19, 2023: AtriCure to participate in the 2023 Bank of America Health Care Conference and host a cryo nerve block therapy investor education webcast
- Feb 01, 2023: AtriCure announces the first patient treated in the LeAAPS clinical trial
- Jan 04, 2023: AtriCure receives 510(k) clearance for Isolator Transpolar Pen (MAX1, MAX5)
- Jan 04, 2023: AtriCure receives additional 510(k) clearance for Isolator Multifunctional Linear Pen
- Jan 03, 2023: AtriCure receives additional 510(k) clearance for Coolrail Linear Pen
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- AtriCure Inc Pipeline Products and Ongoing Clinical Trials Overview
- AtriCure Inc Pipeline Products by Equipment Type
- AtriCure Inc Pipeline Products by Indication
- AtriCure Inc Ongoing Clinical Trials by Trial Status
- AtriCure Inc, Key Facts
- AtriCure Inc, Major Products and Services
- AtriCure Inc Number of Pipeline Products by Development Stage
- AtriCure Inc Pipeline Products Summary by Development Stage
- AtriCure Inc Ongoing Clinical Trials by Trial Status
- AtriCure Inc Ongoing Clinical Trials Summary
- AtriClip System - Stroke - Product Status
- AtriClip System - Stroke - Product Description
- AtriClip System - Stroke - Stand-alone Thoracoscopic Epicardial Left Atrial Appendage Occlusion with AtriClip Device for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation - the Polish Nationwide Registry
- AtriCure Bipolar System - Product Status
- AtriCure Bipolar System - Product Description
- AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) - Product Status
- AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) - Product Description
- CryoICE Ablation System - Atrial Fibrillation - Product Status
- CryoICE Ablation System - Atrial Fibrillation - Product Description
- CryoICE Ablation System - Atrial Fibrillation - AtriCure CryoIce Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo/Epicardial Cardiac Surgery
- cryoSPHERE Cryoablation Probe - Sternotomy - Product Status
- cryoSPHERE Cryoablation Probe - Sternotomy - Product Description
- Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
- Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
- LARIAT Suture Delivery Device - Adjunctive Therapy - Product Status
- LARIAT Suture Delivery Device - Adjunctive Therapy - Product Description
- Next Generation RF Generator - Product Status
- Next Generation RF Generator - Product Description
- AtriCure Inc, Key Employees
- AtriCure Inc, Key Employee Biographies
- AtriCure Inc, Subsidiaries
- Glossary
- AtriCure Inc Pipeline Products by Equipment Type
- AtriCure Inc Pipeline Products by Development Stage
- AtriCure Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific Corp
- Biosense Webster Inc
- St. Jude Medical LLC
- Merit Medical Systems Inc
- Medtronic Plc
